Radiotherapy Side Effect Clinical Trial
Official title:
Evaluating the Feasibility and Efficacy of Photobiomodulation Therapy in the Prevention and Management of Radiotherapy-induced Vaginal Toxicity: a Randomized Controlled Trial
This study aims to investigate the effectiveness of photobiomodulation therapy (PBMT) in the prevention and management of radiotherapy-induced vaginal toxicity (RIVT). Therefore, we hypothesize that PBMT can reduce the severity of RIVT in gynecological cancer patients, increasing the patient's QoL and sexual functioning.
The global cancer burden keeps rising, and the accompanied side effects remain a significant concern. This project focuses on one of such complications: radiotherapy-induced vaginal toxicity (RIVT). The use of external and internal radiotherapy in gynecological cancers can severely impact the patient's vaginal function. This influences the patient's quality of life (QoL), as it significantly limits sexual intercourse and further physical examination. Management of RIVT urgently requires a comprehensive approach. Photobiomodulation therapy (PBMT) is a non-invasive form of phototherapy that utilizes visible and/or near-infrared light to trigger a cascade of intracellular reactions. PBMT can be used to improve wound healing, and to reduce pain, inflammation, and edema. Literature shows that PBMT can be used for treating the genitourinary syndrome of menopause as it stimulates the synthesis of collagen and elastin and promotes vasodilation in the vaginal submucosa. To date, no clinical trials have investigated the positive effects of PBMT on RIVT. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05543239 -
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain
|
N/A | |
| Terminated |
NCT04535908 -
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.
|
N/A | |
| Recruiting |
NCT04115267 -
Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies
|
||
| Recruiting |
NCT05820633 -
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.
|
N/A | |
| Completed |
NCT05880446 -
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)
|
N/A | |
| Recruiting |
NCT05724004 -
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
|
N/A | |
| Recruiting |
NCT04612907 -
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer
|
N/A | |
| Recruiting |
NCT05762900 -
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
|
Phase 2 | |
| Recruiting |
NCT03613506 -
The Role and Intervention of TGF-β in Abdominal Radiation Injury
|
Phase 2 | |
| Completed |
NCT06353724 -
Comparison Between the Effect of Using Conventional and Digital Oral Positional Radiation Stent
|
N/A | |
| Not yet recruiting |
NCT05548504 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
Phase 2 | |
| Recruiting |
NCT05224297 -
Patient Experience Data in Radiation Oncology
|
||
| Recruiting |
NCT05776147 -
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study
|
||
| Completed |
NCT04842409 -
Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery
|
||
| Recruiting |
NCT03742687 -
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
|
N/A | |
| Not yet recruiting |
NCT05614700 -
Prostate Reirradiation Toxicity Outcomes Feasibility Study
|
N/A | |
| Completed |
NCT04027543 -
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
|
||
| Recruiting |
NCT05354596 -
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
|
N/A | |
| Recruiting |
NCT03378856 -
Evaluation of Technological Innovation in Radiotherapy
|